Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
3
users have commented on this narrative
45
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Ooma
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Cloud Migration And Reseller Expansion Will Redefine Digital Communications
Key Takeaways Expanding business subscription revenue and product upgrades are improving recurring income, margins, and earnings visibility, fueled by demand for cloud and POTS-replacement solutions. Growth in targeted industries and geographies, coupled with disciplined innovation and SaaS focus, strengthens Ooma's long-term multi-year revenue and profitability potential.
View narrative
US$17.88
FV
35.2% undervalued
intrinsic discount
5.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
AngioDynamics
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Rising Demand For Minimally Invasive Care Will Expand Med Tech
Key Takeaways Growing global demand for minimally invasive therapies, clinical validation, and regulatory progress are set to expand product adoption and boost revenue and margins. International expansion and operational cost savings initiatives will diversify revenue streams, reinforce profitability, and drive sustained growth across key Med Tech segments.
View narrative
US$18.25
FV
51.9% undervalued
intrinsic discount
6.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
Advantage Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Omni-Channel Trends And Automation Will Redefine Retail Operations
Key Takeaways Investments in advanced data platforms and operational automation are expected to drive client value, revenue growth, efficiency, and improved margins. Shifting retailer priorities toward private brands and third-party partnerships favor Advantage's service offerings, boosting revenue opportunities and long-term earnings growth.
View narrative
US$2.83
FV
36.5% undervalued
intrinsic discount
-0.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
America's Car-Mart
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Digital Payments And Data Analytics Will Expand Auto Finance
Key Takeaways Leveraging analytics, digital tools, and diverse payment options to improve credit quality, reduce losses, and enhance customer experience supports stronger margins and earnings stability. Expansion in inventory, financing, and market reach amid used car industry constraints positions the company for resilient growth and improved competitive standing.
View narrative
US$62.50
FV
28.4% undervalued
intrinsic discount
6.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Bioventus
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Minimally Invasive Nonopioid Pain Management Will Expand With PNS
Key Takeaways Launch of innovative pain management devices and strong growth across diverse product lines position the company for sustained revenue and margin expansion. Operational efficiencies combined with favorable market trends and payer support drive improved profitability and long-term growth momentum.
View narrative
US$12.75
FV
42.2% undervalued
intrinsic discount
5.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Peakstone Realty Trust
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Transformation To Industrial Outdoor Storage Will Build Lasting Resilience
Key Takeaways Transitioning to an industrial outdoor storage platform and recycling office assets strengthens portfolio quality, earnings stability, and future growth prospects. Focus on debt reduction and rent growth enhances balance sheet resilience, recurring income, and potential for accretive acquisitions and higher asset valuations.
View narrative
US$14.67
FV
16.5% undervalued
intrinsic discount
0.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
ITD Cementation India
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
India Urbanization Will Create New Infrastructure Opportunities
Key Takeaways Strong order book across diverse infrastructure segments and robust project pipeline positions the company for sustained topline and multi-year earnings growth. Shift to technically advanced projects and operational efficiencies improves margins and profit stability, supported by enhanced group backing and better financing access.
View narrative
₹768.33
FV
0.07% undervalued
intrinsic discount
20.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 days ago
author updated this narrative
Theravance Biopharma
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Chronic And Respiratory Care Will Fuel Future Market Expansion
Key Takeaways Sustained demand for key therapies and new product approvals support revenue growth, expanded margins, and enhanced operating leverage in both established and emerging markets. Streamlined cost structure, controlled spending, and a robust cash position reduce financial risk while enabling reinvestment in pipeline assets and supporting future earnings growth.
View narrative
US$18.00
FV
26.9% undervalued
intrinsic discount
21.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Global Medical REIT
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Discounted Outpatient Properties Will Unlock Healthcare Real Estate Potential
Key Takeaways Acquisition of outpatient medical properties below market rates and successful re-tenanting are expected to drive rent, occupancy, and earnings growth. Favorable healthcare demographics and disciplined capital management are supporting stable demand, higher margins, and sustained long-term value creation.
View narrative
US$8.97
FV
25.6% undervalued
intrinsic discount
3.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies